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Background: To examine the effects of a multicomponent exercise program on the cognitive function of older
adults with amnestic mild cognitive impairment (aMCI).
Methods: Design: Twelve months, randomized controlled trial; Setting: Community center in Japan; Participants:
Fifty older adults (27 men) with aMCI ranging in age from 65 to 93 years (mean age, 75 years); Intervention:
Subjects were randomized into either a multicomponent exercise (n = 25) or an education control group (n = 25).
Subjects in the multicomponent exercise group exercised under the supervision of physiotherapists for 90 min/d,
2 d/wk, for a total of 80 times over 12 months. The exercises included aerobic exercises, muscle strength
training, and postural balance retraining, and were conducted using multiple conditions to stimulate cognitive
functions. Subjects in the control group attended three education classes regarding health during the 12-month
period. Measurements were administered before, after the 6-month, and after the 12-month intervention period;
Measurements: The performance measures included the mini-mental state examination, logical memory subtest
of the Wechsler memory scale-revised, digit symbol coding test, letter and categorical verbal fluency test, and
the Stroop color word test.
Results: The mean adherence to the exercise program was 79.2%. Improvements of cognitive function
following multicomponent exercise were superior at treatment end (group × time interactions for the
mini-mental state examination (P = 0.04), logical memory of immediate recall (P = 0.03), and letter verbal
fluency test (P = 0.02)). The logical memory of delayed recall, digit symbol coding, and Stroop color word test
showed main effects of time, although there were no group × time interactions.
Conclusions: This study indicates that exercise improves or supports, at least partly, cognitive performance in
older adults with aMCI.
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Population-based studies in older adults performed in
North America, Europe, and Asia report a prevalence of
mild cognitive impairment (MCI) ranging from 11% to 17%
[1-5], and a prevalence of the amnestic MCI (aMCI) sub-
type between 3 and 5% [2,6]. Evidence from both neuro-
psychological and neuroimaging studies have suggested* Correspondence: suzutaka@ncgg.go.jp
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reproduction in any medium, provided the orthat MCI represents a clinical prodrome to degenerative
dementias such as Alzheimer’s dementia (AD) [7,8]. This is
particularly the case with aMCI, which is likely to progress
to AD [9]. Early treatment of mild to moderate AD is asso-
ciated with better responses than later treatment [10], so it
is conceivable that treating MCI may be particularly effect-
ive in delaying the progression to AD.
Clinical aspects have been widely examined as possible
biomarkers for MCI to detect subjects at greater risk of
conversion to dementia. Neuropsychological predictors
of conversion include performance on specific cognitiveLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Suzuki et al. BMC Neurology 2012, 12:128 Page 2 of 9
http://www.biomedcentral.com/1471-2377/12/128tests, particularly those assessing delayed recall and ex-
ecutive functions [11-14]. Reducing or recovering from
identified risk factors is important in the prevention of
the conversion from MCI to AD or to delay the progres-
sion of the prodromal symptoms of dementia.
Epidemiological data suggests that moderate exercise
and physical activity, such as walking, are associated
with a lower risk of dementia [15]. According to these
findings, epidemiological studies and randomized con-
trolled trials examining the effects of exercise have
proposed it is associated with various cognitive bene-
fits [16-25], and a meta-analysis reported that physical
activity or exercise is associated with improvements in
attention, processing speed, and executive function in
older adults with or without cognitive impairments [26-28].
RCT have been conducted to determine the effects of exer-
cise or physical activity on cognitive functions in older adults
with MCI. These studies identified the effects of exer-
cise or physical activity on cognitive function including
general cognitive function, executive function and glu-
cometabolic and hypothalamic-pituitary-adrenal axis
responses in older adults with MCI [16,19,22,23]. How-
ever, because the results of these studies differed largely
due to differences in methodology, sufficient evidence has
not been garnered regarding the relationship between ex-
ercise and cognitive function in aMCI.
We designed the present randomized trial to test
whether 12 months of supervised multicomponent exer-
cise improved cognitive function among older adults with
aMCI. The multicomponent exercise included aerobic ex-
ercise, muscle strength training, and postural balance
retraining. We adopted the multicomponent regimen be-
cause a previous review suggested that participants in com-
bined aerobic and strength training regimens improved
cognitive function to a reliably greater degree than
those in aerobic training alone (0.59 vs. 0.41, SE = 0.043,
n = 101, p < 0.05) [29].
Methods
Participants
In this 12-month randomized controlled trial, the sub-
jects were divided into a multicomponent exercise or an
education control group at the end of the baseline as-
sessment. Study personnel involved in collection of out-
come measures were unaware of each subject’s assigned
group. The Ethics Committee of the National Center for
Geriatrics and Gerontology approved the study protocol.
The purpose, nature, and potential risks of the experi-
ments were fully explained to the subjects, and all sub-
jects gave written, informed consent before participating
in the study.
Subjects in this study were recruited from our volunteer
databases, which included elderly individuals (65 years
and over). The inclusion criteria we used were dwelling inthe community and being 65 years or age or older. 528
prospective subjects with a Clinical Dementia Rating
(CDR) [30] of 0.5, or who complained of memory impair-
ments, were recruited for the initial eligibility assessments.
135 subjects participated in the secondary eligibility
assessments, including neuropsychological tests and mag-
netic resonance imaging. 35 of these 135 subjects were
excluded and the remaining 100 subjects met the defin-
ition of MCI using the Petersen criteria [31]. The objective
memory impairment was defined as having a lower mem-
ory in the Logical Memory II subtest of the Wechsler
memory scale-revised (WMS-LM II) [32]. The cut-off
score to define the aMCI was adjusted by educational
history (0–9 years: <7 points, 10–15 years: <10 points,
more than 16 years: <12 points) [33]. The exclusion
criteria we used included having a CDR = 0, 1, 2, and 3, a
history of neurological, psychiatric, and cardiac disorders
or other severe health issues, use of donepezil, loss of in-
dependence in basic activities of daily living (ADL), and
current participation in other research projects. A diagram
consistent with the Consolidated Standards of Reporting
Trials (CONSORT) [34] that outlines the subject flow
from first contact to study completion is shown in
Figure 1. Fifty older adults (mean age 76.0 ± 7.1 years,
range 65–92 years, male = 27 (54 %), mean education
level 10.9 ± 2.5 years) with aMCI who had objective
memory disabilities and who completed the neuroi-
maging assessments were selected as the subjects in
the study.
Intervention
Subjects in the multicomponent exercise group exer-
cised under the supervision of physiotherapists for
90 min/d, 2 d/wk, for a total of 80 times over 12
months. Two physiotherapists involved in geriatric
rehabilitation and three well-trained instructors conducted
each intervention. The exercise class consisted of 16–17
participants, and each supervised session began with a
10-min warm-up period, followed by 20 min of muscle
strength exercise. The subjects then practiced aerobic
exercise, postural balance retraining, and dual-task
training for 60 min. In the aerobic exercises and postural
balance retraining, subjects completed circuit training
including stair stepping, endurance walking, and walking
on balance boards. The mean intensity of the aerobic
exercises was approximately 60% of maximum heart
rate. Heart rate was monitored after aerobic exercise
each session to take their pulse. One out of every four
classes during the intervention period included outdoor
walking during approximately 20–30 minutes. These
exercises or training were also conducted under multitask
conditions. For example, the subjects in the exercise group
were asked to invent their own poem while walking. In
the ladder training, subjects memorized a step pattern in
85 Excluded
  29 Non-aMCI
  21 Not completed neurological 
tests
  18 Not meeting inclusion criteria
  12 Refuse to participate
    5 Having any medical problem
1,408 Excluded
765 No memory complaint
  32 History of stroke
  35 History of heart disease
  14 Having other medical problem




100 CDR=1 to 3
    3 Refuse to participate135 Individuals screened for 
eligibility by speech therapist 
and MRI scan
1,543 Individuals screened for 
eligibility by interview
25 Randomized to exercise
group
25 Randomized to control
group





24 Completed 12-mo follow-up
1 Lost to follow-up
0 Refused 
1 Medical illness
25 Included in primary analysis 
(2 imputed)
23 Completed 12-mo follow-up
2 Lost to follow-up
1 Refused
1 Gave no reason
Figure 1 Subject flow diagram from the initial contact through the study completion.
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step as quickly and accurately as possible. Before and
after each session of the program, physiotherapists con-
ducted a health check of each subject. The physiothera-
pists and well-trained instructors provided ongoing safety
monitoring to prevent adverse accidents such as falling
during the program. Daily home-based exercise in
addition to structured program and outdoor walking was
recommended to the exercise group. The subjects allo-
cated the exercise group were asked to recording the
amount of time spent on daily home-based exercise
and the daily total steps for pedometer in a notebook.
The subjects made graphs from the records of amount
of time and steps to promote active lifestyle through a
self-monitoring. Attendance at each session was recorded
and a transportation service was provided for the partici-
pants, if necessary, to help the subjects maintain their par-
ticipation in the program.
Subjects in the education control group attended three
education classes regarding health promotion during the
12-month study period. The class provided information
regarding aging, healthy diet, oral care, brain image diag-
nosis, prevention of urinary incontinence, and health
checks. However, the group did not receive specificinformation regarding exercise, physical activity, or cog-
nitive health.
Outcomes
The cognitive function before, after 6-month, and after
12-month intervention period was measured by speech
therapists. Prior to the commencement of the study, all
staff received training from the authors in the correct
protocols for administering all of the assessment mea-
sures included in the study. The assessors introduced
and demonstrated the assessments to facilitate under-
standing of the tests by the participants before they con-
ducted the tests. A speech therapist calculated all of the
results of the cognitive function tests.
The mini-mental state examination (MMSE) was mea-
sured as a general cognitive function [35]. The WMS-
LM I and II [32] was used to assess logical memory
function. In the WMS-LM, two short stories (story A
and B) were read aloud to the subjects, who were then
instructed to recall details of the stories immediately
(WMS-LM I) and after 30 min (WMS-LM II) (total re-
call score = 50) [32]. The digit symbol-coding (DSC)
subset of the Wechsler Adult Intelligence Scale III was
used to assess processing speed [36]. Verbal fluency
Table 1 Baseline characteristics of the subjects
Characteristic Exercise (n=25) Control (n=25)
Age, mean ± SD, y 75.3 ± 7.5 76.8 ± 6.8
Men, No. (%), n 13 (52.0) 14 (56.0)
Educational level, mean ± SD, y 11.1 ± 2.4 10.8 ± 2.7
Blood pressure, mean ± SD, mmHg
Diastolic 77.3 ± 11.1 74.3 ± 10.1
Systolic 152.2 ± 21.0 143.7 ± 21.3
Diagnosis, No. (%), n
Hyper tension (1*) 13 (52.0) 11 (44.0)
Heart disease (1*) 2 (8.0) 0 (0)
Diabetes Mellitus 5 (20.0) 3 (12.0)
Medication, 3 and over 10 (40.0) 11 (44.0)
Blood test, mean ± SD
Total cholesterol, mg/dL 212.6 ± 36.9 202.8 ± 32.2
Triglyceride, mg/dL 146.8 ± 73.7 130.4 ± 112.3
Glucose, mg/dL 116.3 ± 27.1 110.4 ± 23.4
HA1c, % 5.6 ± 0.6 5.4 ± 0.5
Cognitive functions, mean ± SD
MMSE, score 26.8 ± 1.8 26.6 ± 1.6
WMS-LM I, score 12.5 ± 5.9 12.0 ± 4.9
WMS-LM II, score 8.2 ± 5.4 6.9 ± 5.0
DSC, s 47.5 ± 15.4 44.3 ± 16.3
LVFT, score 16.0 ± 5.3 16.9 ± 6.0
CVFT, score 33.1 ± 6.9 31.2 ± 7.7
SCWT-I, s 22.6 ± 9.7 23.4 ± 11.1
SCWT-III, s 42.0 ± 13.7 41.5 ± 17.7
TMIG index, mean ± SD, score
IADL 5.0 ± 0.2 4.9 ± 0.3
Intellectual activity 3.8 ± 0.4 3.8 ± 0.4
Social role 3.6 ± 0.9 3.6 ± 0.8
Total 12.3 ± 1.1 12.3 ± 0.9
GDS, mean ± SD, score 3.0 ± 2.1 2.6 ± 2.0
SD; standard deviation, MMSE; mini-mental state examination, WMS-LM II;
Logical Memory II subtest of the Wechsler memory scale-revised, LVFT; letter
verbal fluency test, CVFT; category verbal fluency test, DSC; digit-symbol
cording, SCWT; Stroop Color and Word Test, TMIG index; Tokyo Metropolitan
Institute of Gerontology index, GDS; Geriatric Depression Scale. * missing
value.
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across 60-second trials [37]. The subject’s listed words
began with a letter composed of Japanese characters for
the three trials (letter verbal fluency test: LVFT) and that
belonged to a semantic category (category verbal fluency
test: CVFT). The total number of correct responses was
used for the analysis. The Stroop Color and Word Test
(SCWT) [39] was used to assess executive function. For
the Stroop test, we used two conditions. First, the sub-
jects were instructed to read out words printed in black
ink (e.g., blue) (SCWT-I). Second, they were shown a
page with color words printed in incongruent colored
inks (e.g., the word blue printed in red ink). The sub-
jects were asked to name the ink color in which the
words were printed (while ignoring the word itself )
(SCWT-III). There were 24 trials for each condition,
and we recorded the time the participants took to read
each condition.
Analysis
The statistical analyses were conducted using SPSS soft-
ware (Version 20; SPSS Inc., Chicago, IL, USA). The in-
dependent samples t-test or Chi-square test was used to
compare the basic characteristics between the exercise
and education control group. The effect of intervention
(exercise vs control) over time on the cognitive functions
was investigated in intention-to-treat (ITT) analyses.
Measurements were analyzed using linear mixed models;
analyses assumed missing at random with missingness
allowed to be driven by variables included in the ana-
lyses. All models included random intercepts to account
for correlations between the repeated measures for each
participant. The fixed components of the models included
effects of group and time and a group × time interaction.
To assess the presence of a group and time effect, where
this may change over time, we first determined the exist-
ence of time, group, and group × time interactions. The
post hoc analyses were made between times and groups
using the Bonferroni method. All statistical significance




There were no significant differences in the baseline
characteristics between the exercise and education con-
trol groups (Table 1). Figure 1 shows the flow of the par-
ticipants from the time of screening to study completion
at 12 months. 47 (exercise group, n = 24) subjects com-
pleted the 12-month follow-up. Two of the twenty-five
subjects in the exercise group (1 man and 1 woman) did
not attend a single session, but were included in the fol-
lowing analyses. The mean adherence to the exercise
program, including these subjects, was 79.2%, and 17subjects (68.0%) in the exercise group attended our
intervention program with more than 80% adherence.
Changes in cognitive function
Table 2 shows changes in cognitive scores over the 12
months across the groups. On the MMSE, there was a
group × time interaction (P = 0.04) indicated benefit of
the exercise over time (Figure 2). Although there were
no main effects of group or time, the control group
showed significant decline in the MMSE score after 6
Table 2 Comparison of cognitive functions between exercise and control groups
Mean difference (95% CI) between before and
after 6 months
Mean difference (95% CI) between before and
after 12 months
Time Group Group × time
Exercise (n=25) Control (n=25) Exercise (n=25) Control (n=25) df F value P value df F value P value df F value P value
MMSE 0.32 (−0.96−1.60) −1.37 (−2.66−−0.07) −0.47 (−1.75−0.81) −0.44 (−1.74−0.86) 92.1 1.17 0.32 d 48.0 2.2 0.14 g 92.1 3.4 0.04
WMS-LM I 3.83 (1.40−6.25) 0.60 (−1.87−3.06) 4.62 (2.19−7.05) 5.00 (2.53−7.46) 90.9 23.0 <0.01 a, b, e, f 47.8 0.9 0.34 g 90.9 3.9 0.03
WMS-LM II 3.79 (1.49−6.10) 2.09 (−0.25−4.43) 5.13 (2.82−7.43) 6.20 (3.86−8.54) 91.1 35.4 <0.01 a, b, e, f 48.1 1.1 0.30 91.1 2.1 0.13
DSC −0.19 (−4.20−3.81) 3.27 (−0.80−7.34) 3.64 (−0.36−7.64) 3.73 (−0.34−7.80) 90.4 5.0 <0.01 48.0 0.2 0.65 90.4 1.4 0.25
LVFT 2.87 (0.57−5.17) −0.97 (−3.31−1.37) 2.99 (0.69−5.30) 1.61 (−0.73−3.95) 91.2 5.9 <0.01 48.3 0.3 0.59 91.2 4.1 0.02
CVFT 1.54 (−1.27−4.35) −1.81 (−4.67−1.04) 1.33 (−1.48−4.14) −1.61 (−4.46−1.25) 91.2 0.02 0.98 48.5 3.1 0.08 91.2 2.5 0.09
SCWT-I −3.30 (−7.56−0.96) −0.98 (−5.30−3.34) −3.68 (−7.94−0.58) −3.20 (−7.52−1.12) 91.5 3.9 0.02 47.7 0.73 0.40 91.5 0.5 0.62
SCWT-III −4.70 (−12.72−3.33) 0.15 (−8.00−8.30) −2.61 (−10.64−5.42) −4.57 (−12.72−3.58) 92.0 1.2 0.31 48.8 0.009 0.92 92.0 1.1 0.34
MMSE; mini-mental state examination, WMS-LM; Logical Memory subtest of the Wechsler memory scale-revised, DSC; digit-symbol cording, LVFT; letter verbal fluency test, CVFT; category verbal fluency test, SCWT;
Stroop Color and Word Test, TMIG; Tokyo Metropolitan Institute of Gerontology index.
a P < .05; significant differences between before and after 6 months in the exercise group, b P < .05; significant differences between before and after 12 months in the exercise group, c P < .05; significant differences
between after 6 months and 12 months in the exercise group, d P < .05; significant differences between before and after 6 months in the control group, e P < .05; significant differences between before and after 12
months in the control group, f P < .05; significant differences between after 6 months and 12 months in the control group, g P < .05; significant differences between the exercise and control groups at after 6 months,


































































Figure 2 Changes in the MMSE, WMS, and LVFT scores. MMSE; mini-mental state examination, WMS-LM I; Logical Memory I subtest of the
Wechsler memory scale-revised, LVFT; letter verbal fluency test. Panels showed change in MMSE, WMS-LM I, and LVFT scores before, after 6
months, and after 12 months intervention. Solid and dashed lines indicate the exercise and control groups, respectively. Group mean and
standard errors are shown in older adults with amnestic mild cognitive impairment. The linear mixed models revealed significant group × time
interactions in MMSE (P = 0.04), WMS-LM I (P = 0.03), and LVFT (P = 0.02).
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there was significant differences between the groups at
after 6 months (P < 0.05).
For the WMS-LM I, there was a group × time inter-
action (P = 0.03); there were an overall effect of time
and no main effect of group (Figure 2). In the post hoc
analysis, the exercise group showed significant increase
in the WMS-LM I score after 6 and 12 months com-
pared to before intervention (P < 0.05) and the control
group showed significant increase after 12 months
compared to before intervention and after 6 months
(P < 0.05). There was a significant difference between
the groups at 6 months (P < 0.05).
On the LVFT, there was a group × time interaction
(P = 0.02); there were an overall effect of time and no
main effect of group (Figure 2). In the post hoc analysis,
There were no significant differences between the times
and groups.
The WMS-LM II, DSC, and SCWT-I showed main ef-
fect of time, although there were no group × time inter-
action and main effect of group. In the post hoc analysis,
the exercise group showed significant increase in the
WMS-LM II score after 6 and 12 months compared to
before intervention (P < 0.05) and the control group
showed significant increase after 12 months compared
to before intervention and after 6 months (P < 0.05).
There were no significant differences between the
groups at each timepoints (Table 2).
Discussion
There was a significant group × time interaction on the
MMSE, WMS-LM I, and LVFT scores. Twelve months
of multicomponent exercise improved cognitive function
in older adults with aMCI relative to the education con-
trol group. In particular, positive effects were observed
for general cognitive function, immediate memory, andlanguage ability, which is consistent with findings in cog-
nitively intact adults [28]. A recent randomized con-
trolled trial has been described as providing verification
of the benefits of exercise in elderly adults with MCI
[23]. In that study, 152 participants were randomly
assigned to an aerobic exercise group and a non-aerobic
exercise group, and to a vitamin B group and a placebo
group, and a one-year intervention was carried out. The
participants exercised twice weekly for 60 minutes each
time. For the aerobic exercises, they walked together in
groups. The results showed that aerobic exercise has no
significant effect in improving cognitive function. How-
ever, these results were based on an intention-to-treat
analysis, which included 30 participants who did not at-
tend the exercise sessions. Had those elderly adults who
had a high attendance rate among the aerobic exercise
group been included in the analysis, then the results
would have shown increased memory and attention,
confirming the effectiveness of aerobic exercise in elder
adults with MCI, though only to a limited extent. In an-
other recent report, when elderly adults with MCI (a
mean age of 70 years) engaged in aerobic exercise four
times every week over the course of six months with a
heart rate reserve of 75% to 85%, executive function sig-
nificantly improved [16].
The present study shows that significant interactions
were observed in general cognitive function, immediate
memory, and verbal fluency between the groups, al-
though intervention effects on delayed memory, proces-
sing speed, and executive control did not reach
significance. Lautenschlager et al. reported that physical
activity and behavioral interventions improve general
cognitive function [19]. The multicomponent exercise
training used in the current study also included aerobic
exercise and behavioral interventions, such as self-
monitoring of home-based exercise. Our results further
Suzuki et al. BMC Neurology 2012, 12:128 Page 7 of 9
http://www.biomedcentral.com/1471-2377/12/128supported the idea that a composite approach including
aerobic exercise and behavioral interventions can have
beneficial effects on cognitive function in aMCI patients.
Older adults with aMCI exhibit greater decreases in
memory function than in other cognitive functions, rela-
tive to healthy older adults [40]. The cognitive deficits in
aMCI increase the risk of conversion from MCI to AD
[11,12]. Enhancing cognitive function, especially mem-
ory, in MCI may prevent conversion from MCI to AD in
older adults. Our multicomponent exercise program
involved cognitive loads during exercise. In other words,
exercise was conducted under multitask conditions such
as dual-task stimulation or while learning tasks during
the exercises [41]. Our multicomponent exercise pro-
gram, involving aerobic exercise, muscle strength, and
additional cognitive demand, has some advantages for
improving cognitive function over aerobic exercise alone,
including possibly increasing logical memory in older
adults with aMCI. The WMS-LM I scores in the educa-
tion control group increased significantly at 12 months
compared to before and after 6 months. The education
control group received reports of the results of the three
assessments and lectures regarding health. We suggest
that these educational approaches may be useful in
maintaining healthy behavior, such as starting cognitive
training or intellectual activities. In fact, the subjects in
the control group had fewer cessations of intellectual ac-
tivity, e.g. culture lessons, than the exercise group during
the 12-month period (−9% vs. −19%).
Baker et al. reported that high intensity aerobic exer-
cise increased VFT scores in older women with MCI
[16]. Early in the dementia process, the ability to con-
sciously access lexical information about a target word is
impaired while the overall semantic system is intact [42],
whereas later in the disease, the integrity of the entire
system is compromised, resulting in impaired name re-
call in structured tasks and spontaneous conversation
[42,43]. Fluency tests tap into lexical and semantic re-
trieval operations and may be able to measure these spe-
cific aspects of language breakdown in aMCI patients. In
a functional neuroimaging study using near infrared
spectroscopy, patients with AD showed decreased brain
activation patterns compared with healthy controls dur-
ing the conduct of VFT. Significant correlations between
brain activation and performance in the LVFT for de-
mentia patients were found [44]. In the present study,
multicomponent exercise provided positive effects on
LVFT scores in the aMCI subjects, who had a higher risk
of dementia [45].
The present study has several limitations. The small
sample size means that replication with a larger group of
adults with MCI would be beneficial. Other limitations
include unknown group differences in the risk factors of
cognitive decline and AD, such as apolipoprotein E ε4genotypes [46], and inflammation [47], although there
were no significant differences between the groups in
hypertension, diabetes mellitus, medications, biomarkers
of lipid metabolism, physical performance, instrumental
ADL functioning, and depressive moods. In addition, it
is possible that the improvement in the exercise group
resulted from the social contact that the intervention
group received. This possibility cannot be completely
excluded with the present design and should be
addressed in future studies.
Conclusions
Twelve months of exercise improved cognitive function
in older adults with aMCI relative to the education con-
trol group. In particular, positive effects were observed
for general cognitive function, immediate memory, and
language ability. A future follow-up investigation is
required to determine whether the effect is associated
with prevention or delayed onset of dementia in older
adults with aMCI.
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